Location: Home
  • search
  • go
  • Relate News
  • 3/25/2021Eli Lilly and Innovent Jointly Launched TYVYT (sintilimab injection) f...
  • 3/25/2021CPIA Introduces the Pharmaceutical Industry Compliance Code
  • 3/25/2021Shanghai Passes Law to Facilitate Traditional Chinese Medicine
  • 3/24/2021HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combo with Ti...
  • 3/24/2021China Declares Early Success in Expanding Online Medical Services
  • 3/24/2021BMS to Offer Steeper Discount for Opdivo in China, Cutting Price to ...
  • 3/24/2021Hutchmed Sells Non-core OTC Chinese JV with Baiyunshan for $169M
  • 3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...
  • 3/24/2021Pharma Manufacturing Industry Lag and Potential for China's Five-Year ...
  • 3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...
  • 3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...
  • 3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...
  • 3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations
  • 3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor
  • 3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report
  • 3/22/2021Bayer Launches Prostate Cancer Drugs Nubeqa and Xofigo in China
  • 3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum
  • 3/19/2021Recent Executive Moves
  • 3/18/2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC...
  • 3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...
  • 3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection
  • 3/18/2021Ping An Good Doctor: Cross-Sectional Survey
  • 3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...
  • 3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...
  • 3/16/2021Chinese Chemical Drug Manufacturing Industry Revenue Down Slightly in ...
  • 3/16/2021Italfarmaco Group Agreed with Luye Pharma to Commercialize Rivastigmi...
  • 3/16/2021Pfizer to Halt Biosimilar Production in China and Sell Its Hangzhou Bi...
  • 3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept
  • 3/16/2021BeiGene Announces Acceptance of a Supplemental Biologics License Appli...
  • 3/16/2021Patent Term Extension in China
  • Page:104/367 Total number of articles:10990: [First][<<] [102] [103] [104] [105] [106] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group